<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03682783</url>
  </required_header>
  <id_info>
    <org_study_id>81300776</org_study_id>
    <nct_id>NCT03682783</nct_id>
  </id_info>
  <brief_title>Artificial Intelligence-assisted Glaucoma Screening (AIAGS)</brief_title>
  <official_title>The Development of Artificial Intelligence-assisted Glaucoma Screening Program</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will develop an artificial intelligence (AI) program for the screening of
      glaucoma.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We have realized that the glaucomatous optic neuropathy is irreversible. But if early
      detection and early intervention can be performed to control the development of the disease,
      it can greatly reduce the blindness rate of glaucoma, improve the life quality and
      physiological and mental health of patients, and alleviate the social burden. Therefore,
      screening and early diagnosis of glaucoma is the focus of glaucoma prevention.

      China has a population of 1.3 billion, which greatly increase the difficulty of disease
      screening. In recent years, the intersection of artificial intelligence (AI) technology and
      modern medicine has made efficient and rapid disease screening possible.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2018</start_date>
  <completion_date type="Anticipated">October 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The specificity of the algorithm for diagnosing glaucoma</measure>
    <time_frame>from January 2020 to March 2021</time_frame>
    <description>The specificity of the algorithm for diagnosing glaucoma will be calculated ...</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The sensitivity of the algorithm for diagnosing glaucoma</measure>
    <time_frame>from January 2020 to March 2021</time_frame>
    <description>The sensitivity of the algorithm for diagnosing glaucoma will be calculated .</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">8000</enrollment>
  <condition>Glaucoma Eye</condition>
  <arm_group>
    <arm_group_label>Fundus Image</arm_group_label>
    <description>Glaucomatous and Non-glaucomatous fundus images that have been taken from the last 5 years in Shanghai General hospital.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Fundus Image</intervention_name>
    <description>Fundus image of optic nerve</description>
    <arm_group_label>Fundus Image</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Both glaucoma and non-glaucoma patients who can complete fundus image test will be
        enrolled.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  able to complete fundus images

        Exclusion Criteria:

          -  unable to complete fundus images
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Haiyan Wang, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Haiyan Wang, Ph.D.</last_name>
    <phone>+86 15000096256</phone>
    <email>catherinecnc81@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kun Liu, Ph.D.</last_name>
    <phone>+86 36126112</phone>
    <email>drliukun@sjtu.edu.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Shanghai General Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200080</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>September 21, 2018</study_first_submitted>
  <study_first_submitted_qc>September 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 25, 2018</study_first_posted>
  <last_update_submitted>September 21, 2018</last_update_submitted>
  <last_update_submitted_qc>September 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine</investigator_affiliation>
    <investigator_full_name>Haiyan Wang</investigator_full_name>
    <investigator_title>Attending of Ophthalmology, M.D. Ph.D.</investigator_title>
  </responsible_party>
  <keyword>Artificial Intelligence; Glaucoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

